134 related articles for article (PubMed ID: 30354306)
21. AHA assesses the impact of genotyping on diagnosis of genetic cardiac disease. American Heart Association.
Morey SS
Am Fam Physician; 1999 May; 59(10):2915-6, 2918. PubMed ID: 10348078
[No Abstract] [Full Text] [Related]
22. Multiplex targeted high-throughput sequencing for Mendelian cardiac disorders.
Fokstuen S; Makrythanasis P; Nikolaev S; Santoni F; Robyr D; Munoz A; Bevillard J; Farinelli L; Iseli C; Antonarakis SE; Blouin JL
Clin Genet; 2014 Apr; 85(4):365-70. PubMed ID: 23590259
[TBL] [Abstract][Full Text] [Related]
23. QT dispersion in alpha-myosin heavy-chain familial hypertrophic cardiomyopathy mice.
Bevilacqua LM; Maguire CT; Seidman JG; Seidman CE; Berul CI
Pediatr Res; 1999 May; 45(5 Pt 1):643-7. PubMed ID: 10231857
[TBL] [Abstract][Full Text] [Related]
24. Using whole exome sequencing to walk from clinical practice to research and back again.
Schuler BA; Prisco SZ; Jacob HJ
Circulation; 2013 Mar; 127(9):968-70. PubMed ID: 23388216
[No Abstract] [Full Text] [Related]
25. Impediments to DNA testing and cascade screening for hypertrophic cardiomyopathy and Long QT syndrome: a qualitative study of patient experiences.
Smart A
J Genet Couns; 2010 Dec; 19(6):630-9. PubMed ID: 20680418
[TBL] [Abstract][Full Text] [Related]
26. Genetic testing for inherited cardiac arrhythmias.
Fowler SJ; Cerrone M; Napolitano C; Priori SG
Hellenic J Cardiol; 2010; 51(2):92-103. PubMed ID: 20378510
[No Abstract] [Full Text] [Related]
27. The role of genetic testing in paediatric syndromes of sudden death: state of the art and future considerations.
McCormack J
Cardiol Young; 2009 Nov; 19 Suppl 2():54-65. PubMed ID: 19857351
[No Abstract] [Full Text] [Related]
28. Yield of molecular and clinical testing for arrhythmia syndromes: report of 15 years' experience.
Hofman N; Tan HL; Alders M; Kolder I; de Haij S; Mannens MM; Lombardi MP; Dit Deprez RH; van Langen I; Wilde AA
Circulation; 2013 Oct; 128(14):1513-21. PubMed ID: 23963746
[TBL] [Abstract][Full Text] [Related]
29. Molecular biology of heart disease. Synopsis of the pathophysiological basis of cardiac hypertrophy, familial hypertrophic cardiomyopathy, long QT syndrome and Marfan syndrome.
Kurabayashi M; Yazaki Y
Intern Med; 1996 Apr; 35(4):243-8. PubMed ID: 8739775
[TBL] [Abstract][Full Text] [Related]
30. [Molecular genetics of cardiovascular diseases].
Schunkert H; Hense HW
Dtsch Med Wochenschr; 1995 Apr; 120(15):533-9. PubMed ID: 7720536
[No Abstract] [Full Text] [Related]
31. Peripartum cardiomyopathy presenting with syncope due to Torsades de pointes: a case of long QT syndrome with a novel KCNH2 mutation.
Nishimoto O; Matsuda M; Nakamoto K; Nishiyama H; Kuraoka K; Taniyama K; Tamura R; Shimizu W; Kawamoto T
Intern Med; 2012; 51(5):461-4. PubMed ID: 22382559
[TBL] [Abstract][Full Text] [Related]
32. Neonatal long QT syndrome due to a de novo dominant negative hERG mutation.
Beery TA; Shooner KA; Benson DW
Am J Crit Care; 2007 Jul; 16(4):416, 412-5. PubMed ID: 17595376
[TBL] [Abstract][Full Text] [Related]
33. A new role for calmodulin in ion channel biology.
Roden DM
Circ Res; 2006 Apr; 98(8):979-81. PubMed ID: 16645144
[No Abstract] [Full Text] [Related]
34. Post-mortem genetic testing in a family with long-QT syndrome and hypertrophic cardiomyopathy.
Kane DA; Triedman J
Cardiovasc Pathol; 2014; 23(2):107-9. PubMed ID: 24322056
[TBL] [Abstract][Full Text] [Related]
35. Implantable defibrillators in long QT syndrome, Brugada syndrome, hypertrophic cardiomyopathy, and arrhythmogenic right ventricular cardiomyopathy.
Dohadwala M; Link MS
Cardiol Clin; 2014 May; 32(2):305-18. PubMed ID: 24793806
[TBL] [Abstract][Full Text] [Related]
36. Clinical and Genetic Diagnosis of Nonischemic Sudden Cardiac Death.
Jiménez-Jáimez J; Alcalde Martínez V; Jiménez Fernández M; Bermúdez Jiménez F; Rodríguez Vázquez Del Rey MDM; Perin F; Oyonarte Ramírez JM; López Fernández S; de la Torre I; García Orta R; González Molina M; Cabrerizo EM; Álvarez Abril B; Álvarez M; Macías Ruiz R; Correa C; Tercedor L
Rev Esp Cardiol (Engl Ed); 2017 Oct; 70(10):808-816. PubMed ID: 28566242
[TBL] [Abstract][Full Text] [Related]
37. NOS1AP Polymorphisms Modify QTc Interval Duration But Not Cardiac Arrest Risk in Hypertrophic Cardiomyopathy.
Earle N; Ingles J; Bagnall RD; Gray B; Crawford J; Smith W; Shelling AN; Love DR; Semsarian C; Skinner JR
J Cardiovasc Electrophysiol; 2015 Dec; 26(12):1346-51. PubMed ID: 26332198
[TBL] [Abstract][Full Text] [Related]
38. Long QT syndrome in extensive infective endocarditis complicating hypertrophic obstructive cardiomyopathy.
Yuan SM; Demesthenous E; Coman V
Kardiol Pol; 2009 Jan; 67(1):53-7. PubMed ID: 19253191
[TBL] [Abstract][Full Text] [Related]
39. Genetics of cardiovascular disease.
Cymet T
Compr Ther; 2010; 36():18-9. PubMed ID: 21229815
[TBL] [Abstract][Full Text] [Related]
40. Genetics and cardiovascular disease.
Allen JK
Nurs Clin North Am; 2000 Sep; 35(3):653-62. PubMed ID: 10957680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
